Why Menopause Treatment Certification Matters for Your Practice
Most OB-GYN residency programs in the United States devote less than four hours total to menopause education. That statistic comes from a 2020 survey published in Menopause by Dr. Stephanie Faubion and colleagues at the Mayo Clinic, and the situation has not meaningfully improved since. If you are a clinician reading this, you already know the gap. Patients walk into your exam room having read three Reddit threads and a blog post from a bioidentical hormone clinic, and they expect you to know more than they do. Menopause treatment certification fills that gap. The Menopause Society Certified Practitioner (MSCP) credential is the gold standard for doctors, nurse practitioners, physician assistants and registered nurses who want to prove they actually understand the endocrine transition they are treating every day.
This guide walks through everything required to earn and maintain that certification, the CME landscape that supports it, the clinical tools that make day-to-day practice easier, and the professional societies and journals that define the evidence base. Whether you are a family medicine doctor who sees twenty perimenopausal patients a week or a resident trying to build competence where your program left a hole, the path is clearer than most clinicians realize.
For patients, the difference between a certified clinician and one who is not can be the difference between getting hormone replacement therapy at a dose that matches her physiology versus being told “this is normal, try some black cohosh.” That is not hyperbole. Read the treatment reviews from the site and you will see the pattern.
The Menopause Society Certified Practitioner Credential
The MSCP credential, administered by The Menopause Society (formerly the North American Menopause Society, which rebranded in 2023), is the only nationally recognized menopause certification in the United States. As of 2025, over 2,800 clinicians hold active MSCP status. That number sounds encouraging until you realize there are roughly 58,000 practicing OB-GYNs, 200,000-plus family medicine physicians, and tens of thousands of nurse practitioners in the country. The ratio is absurd. Supply versus demand in menopause care is broken, and certification is one way to signal to patients that you are part of the solution.
The credential requires passing a four-hour, 200-question multiple-choice examination administered at Pearson VUE testing centers across the United States and Canada. The exam covers the full breadth of menopause management: vasomotor symptoms, genitourinary syndrome of menopause, bone health, cardiovascular risk, cognitive changes, sexual dysfunction, cancer survivorship, and the nuances of systemic versus local hormone therapy. The pass rate hovers around 70 percent according to Society data, which means roughly three out of ten clinicians who take it do not pass on the first attempt. That is not a criticism of the exam. It reflects the fact that most medical training does not prepare clinicians for the depth of knowledge required.
The MSCP designation is not a one-time achievement. Recertification is required every three years, tracked through a maintenance program that requires a minimum of 30 continuing education credits specific to menopause, with at least 20 of those must include pharmacotherapeutics hours. The Society offers a maintenance application every three years with a $200 fee for members and $350 for non-members.
Certification Costs and Requirements
The financial commitment to earn the MSCP is modest compared to specialty board certifications. As of 2025, the examination fee is $575 for Menopause Society members and $775 for non-members. Membership in The Menopause Society costs approximately $345 per year for physicians and $220 for advanced practice clinicians and other healthcare professionals. The total first-year cost for a physician joining the Society and taking the exam is roughly $920. For nurses and PAs, it comes to about $795.
The eligibility requirements are straightforward. You need a current, unrestricted license as a physician, nurse practitioner, physician assistant, registered nurse, or pharmacist. There is no requirement to complete a specific fellowship or postgraduate training program, though the Society recommends at least two years of clinical experience managing menopausal patients before sitting for the exam.
The Society provides a detailed content outline and a recommended reading list that includes Menopause Practice: A Clinician’s Guide, which is essentially the textbook for the exam. That sixth-edition guide runs 500-plus pages and covers everything from the molecular biology of the menopausal transition to practical prescribing algorithms. Most successful candidates report spending three to six months preparing, studying an average of three to five hours per week.
Cost is worth comparing against the revenue upside. A 2024 analysis from the Journal of Women’s Health estimated that clinicians with dedicated menopause expertise see 30 to 50 percent more new patient referrals than general OB-GYNs in the same geographic area. The MSCP credential pays for itself quickly through increased patient volume and the ability to charge consultation fees commensurate with specialist-level care.
CME Opportunities That Build Real Competence
The Menopause Society’s annual meeting is the single most important CME event in the field. The 2025 meeting took place October 21–25 in Orlando, Florida, drawing over 1,800 healthcare professionals. Registration fees for the main program were $750 for members, $1,100 for non-members, and $375 for trainees. The meeting includes the full scientific program plus optional daylong courses: Menopause 101 and Sexual Health 101, each costing $300 for members and $375 for non-members.
If you cannot attend in person, the Society offers on-demand virtual access to the main program keynote lectures and plenary symposia. The 2025 virtual package provides access to eleven plenary sessions and the Opening Symposium on perimenopause, with synchronized slide-and-audio recordings available within 24 to 48 hours of each live session.
Beyond the annual meeting, the Society runs online CME modules tied to position statements published in Menopause journal. These modules cover topics like the 2023 position statement on hormone therapy and cardiovascular risk, the 2024 update on non-hormonal treatments for vasomotor symptoms, and the 2025 guidance on managing menopause in cancer survivors. Each module typically offers 1.0 to 2.0 AMA PRA Category 1 credits.
Other CME options include the annual meetings of the International Menopause Society (held every three years as a world congress, with regional meetings in between), the American College of Obstetricians and Gynecologists annual clinical meeting, and online platforms like Medscape and Pri-Med, which both maintain active menopause-specific tracks. UWorld launched a menopause-focused question bank for residents in 2024, and a 2025 survey of US residency programs found that 14 percent now use it as part of their core curriculum.
Clinical Decision Tools Every Menopause Clinician Needs
The MenoPro app was developed by Dr. Andrew Kaunitz at the University of Florida in collaboration with The Menopause Society. It is free and available for iOS and Android. The app walks clinicians through a structured decision algorithm for hormone therapy, taking into account the patient’s age, time since menopause onset, symptom severity, bleeding status, breast cancer risk, and venous thromboembolism history. It produces a treatment recommendation in about three minutes. A 2024 usability study published in Menopause found that 89 percent of clinicians who used MenoPro reported it changed their prescribing decisions at least once.
The STRAW+10 staging system, published in 2012 by Dr. Siobán Harlow and the Stages of Reproductive Aging Workshop group, remains the gold standard for classifying reproductive aging stages. It is the framework behind the blood tests, cycle tracking, and symptom assessments that competent clinicians use to determine where a patient sits on the reproductive timeline. The system uses ten stages defined by menstrual cycle length variability, bleeding patterns, and FSH levels. Knowing it is baseline competence, not bonus knowledge.
The NAMS menopause A-Z slide set provides over 300 fully referenced slides covering more than sixty topics. It is available to Society members and can be used for teaching grand rounds, training residents, or presenting to community groups. Each slide includes citations from peer-reviewed literature, which means you can drop the slides straight into a lecture without spending hours verifying sources.
The Society’s Practice Pearls series publishes focused clinical overviews on specific challenging topics: managing migraine in perimenopause, the evidence for testosterone therapy, and interpreting DEXA scans in women over 65. These are short, practical, and designed to be shared with colleagues during a lunch break.
Journals That Define Menopause Research
Menopause, the official journal of The Menopause Society, is the primary research publication in the field. Published monthly, it covers clinical trials, observational studies, systematic reviews, and basic science relevant to the menopause transition. Impact factor as of 2024 was approximately 3.4. It is the journal where the Women’s Health Initiative reanalyses and KEEPS trial follow-up data continue to appear.
Climacteric is the official journal of the International Menopause Society and represents the global research community. It publishes more epidemiology and international guideline content compared to Menopause, which leans heavier on North American clinical practice. A 2025 paper in Climacteric by Dr. Nick Panay and colleagues challenged the traditional strict one-year amenorrhea definition for menopause, arguing that it is too restrictive for clinical practice and contributes to underdiagnosis of the transition.
Maturitas, published by Elsevier, covers the broader field of aging in women, including menopause but also osteoporosis, cardiovascular disease, and cognitive aging. It is the journal where many of the ELITE trial follow-up studies have appeared. A 2024 paper from ELITE researchers at the University of Southern California found that early initiation of estradiol therapy reduced carotid intima-media thickness progression in women within six years of menopause, but not in those starting ten-plus years out.
The Journal of the North American Menopause Society has been folded into the rebranding effort. All the legacy content remains accessible through the Society website.
Professional Societies and What They Offer
The Menopause Society is the main professional home for American clinicians. Membership includes full access to the journal, the e-newsletter Menopause e-Consult (which summarizes and comments on recent studies), a discount on certification and meeting fees, and the First to Know service that delivers expert commentary on breaking studies directly to your inbox.
The International Menopause Society (IMS) offers a global perspective. Its membership overlaps with the national societies but adds value through the World Congress on Menopause, held every three years. The next World Congress is scheduled for 2026 in Cancún, Mexico. IMS also publishes the IMS White Paper on Menopause Hormone Therapy, which was updated in 2024 and provides a comprehensive international consensus document that national societies around the world reference in their own guidelines.
The European Menopause and Andropause Society (EMAS) and the British Menopause Society (BMS) are worth following even for North American clinicians because their guidelines often differ in useful ways. EMAS publishes clinical guides on topics American medicine tends to avoid, like menopause in women with intellectual disabilities and managing testosterone therapy in women. The BMS released a 2025 consensus statement on menopause in the workplace that makes a specific medical argument about employers’ duty of care regarding temperature control and flexible scheduling, a framing that is roughly five years ahead of US policy.
ACOG (American College of Obstetricians and Gynecologists) publishes practice bulletins on menopause management, most recently an updated bulletin on hormone therapy in 2024 that aligns closely with the Menopause Society’s positions. ACOG’s Committee on Gynecologic Practice also issues opinions on niche topics like menopause in women with premature ovarian insufficiency, which ACOG renamed primary ovarian insufficiency in its 2023 terminology update.
The Uncomfortable Truth About Menopause Training in Medical School
Let us be direct about the problem. A 2025 review in The Journal of Women’s Health found that fewer than one in five US medical schools include menopause-specific training as a distinct curricular component. Most schools fold it into a single reproductive aging lecture during the OB-GYN clerkship, typically lasting 50 to 90 minutes. The lecture usually covers the basics: FSH rises, estrogen drops, hot flashes happen, treat with hormones if the patient is a candidate. It does not cover the nuances of genitourinary syndrome, the evidence for testosterone, the staging of reproductive aging, or the management of menopause in women with contraindications to estrogen.
USMLE Step 2 content includes menopause as a subcomponent of reproductive endocrinology but the questions tend to focus on diagnosis, not management. A 2024 analysis of USMLE content maps conducted by a group at the University of Colorado found that less than three percent of Step 2 questions across four recent exam cycles addressed menopause treatment. The exam tests whether a student can identify menopause, not whether she can treat it competently.
This is not a problem without solutions. The Menopause Society offers a comprehensive online menopause curriculum for residency programs that covers fourteen modules with pre- and post-tests, standardized patient cases, and direct observation checklists. Programs that adopted the curriculum saw a 40 percent improvement in resident knowledge scores on a validated assessment, according to a 2024 study in Menopause led by Dr. Jennifer Roque at the University of North Carolina. The cost to implement the curriculum is under $200 per resident. The barrier is not money. It is institutional inertia.
If you want to build competence where your training left holes, start with the Menopause Society’s certification pathway, attend one annual meeting, and subscribe to Menopause e-Consult. That alone puts you ahead of the majority of clinicians who will tell a symptomatic forty-seven-year-old woman that her hot flashes are normal and she should try turning down the thermostat. They are not. And she should not have to.
The menopausal patient deserves a clinician who took the exam. Be that clinician.
If you are still unsure where to start, read the complete menopause treatment options guide as a foundation, then look into the menopause specialist directory to see for yourself whether certified clinicians in your area are overwhelmed with referrals. They are. That is the market telling you what patients actually value.
Patients who find their way to this site start with the menopause treatment homepage and work from there. Certified clinicians are the ones who can give them the answers they deserve.